Peptide Therapy.
Peptides are signalling molecules. They tell cells to start or stop doing something. That is genuinely powerful, and it is also exactly why what you receive has to be decided by a physician rather than chosen from a list.
- Prescribed only after clinical evaluation, never selected from a menu
- Individualized to your history, your results, and your goals
- Limited to what is clinically appropriate and legally available
- Monitored, with a defined point at which we reassess
Short chains that carry instructions.
A peptide is a short chain of amino acids, the same building blocks that make up proteins. Your body already makes and uses them constantly. Insulin is a peptide. So are the GLP-1 medications that have reshaped metabolic care over the past few years.
What distinguishes peptides from most drugs is specificity. Rather than broadly altering chemistry, they carry a targeted signal to a particular receptor. That precision is the appeal, and it is also why dose, indication, and monitoring matter more here rather than less.
Evaluation before anything is prescribed
Evaluation first. Always.
Most of what is marketed as peptide therapy skips the first three of these steps. We do not, and the reason is not caution for its own sake.
Evaluation
A physician reviews your history, your current medications, your goals, and your diagnostics. Nothing is offered before this, and for some people the outcome of this step is that peptide therapy is not appropriate at all.
- Full history and medication review
- Diagnostics where they inform the decision
- An honest answer, including no
Indication
There has to be a specific reason, tied to something we found rather than something you read about. A peptide that suits one person's evaluation may be entirely wrong for another with the same goal.
- Driven by findings, not by trend
- Weighed against alternatives, including doing nothing
- Explained to you in terms you can assess
What Is Available
Peptides sit in an actively evolving regulatory landscape. Some are approved medications with substantial trial evidence behind them. Others are not approved for human use. We work only within what is clinically appropriate and legally available.
- Approval status is part of the clinical decision
- We will tell you where something sits
- Regulatory position is actively changing
Monitoring
Anything prescribed is reviewed. We set a point at which we reassess, look at what changed, and decide whether to continue, adjust, or stop. Prescribing without that follow up is not something we consider acceptable.
- A defined review point, agreed in advance
- Objective markers where they apply
- Stopping is a legitimate outcome
Where the evidence actually sits.
Peptide therapy is not one thing, and treating it as one thing is how people get misled. The category spans rigorously tested medicines and compounds that have never been through a human trial.
Some peptides are established medicine
Roughly 130 peptide drugs hold FDA approval. Insulin has been in clinical use for a century. GLP-1 medications went through years of human trials before approval and have measurably changed metabolic care. These are peptides, and the evidence behind them is substantial.
Others have not been through that process
Many compounds marketed as peptide therapy are not approved for human use, and several have not been studied for safety or efficacy in humans at all. Popularity is not evidence, and the gap between the two is currently wide in this field.
The regulatory position is moving
The FDA is actively reviewing which peptide substances are appropriate for pharmaceutical compounding, examining safety evidence, clinical need, and whether approved alternatives already exist. This is a live process, and what is available may change. We will tell you where things stand when you ask.
And who it is not for.
This is a clinical service. The honest position is that it suits fewer people than the marketing around it suggests.
People who want a physician to assess whether this is appropriate rather than assume it is
Those who have completed diagnostics and have findings worth acting on
Anyone who wants the regulatory picture explained plainly before deciding
People prepared to be monitored and reassessed rather than prescribed and forgotten
Not for anyone seeking a specific compound they have already decided on
Not appropriate during pregnancy, with certain conditions, or alongside some medications
What actually happens.
This is a clinical process rather than a session you book, and it runs on a different timeline to the rest of the facility.
Consultation
- Full history, current medications, and supplements reviewed
- Your goals discussed honestly against what is realistic
- Existing labs or diagnostics reviewed, or ordered where needed
- You may leave with a recommendation against, and that is a valid result
Decision
- Any recommendation is explained with its reasoning
- Approval status and evidence base stated plainly
- Alternatives considered, including non pharmacological options
- You decide with the full picture rather than a pitch
Monitoring
- A review point set in advance rather than left open
- Objective markers rechecked where they apply
- Adjusted, continued, or stopped based on what we find
- Coordinated with your other physicians on request
Monitored, with a defined point at which we reassess
Stated as process, not outcomes.
We describe what we do rather than what any compound will achieve, because the second depends entirely on the first.
A physician evaluation that assesses whether peptide therapy is appropriate for you at all
Review of your full history, medications, and supplements before anything is considered
Diagnostics ordered or reviewed where they inform the clinical decision
A clear statement of approval status and evidence base for anything recommended
Consideration of alternatives, including non pharmacological approaches
Individualized prescribing rather than a standard protocol applied to everyone
A defined monitoring point with objective markers where they apply
Coordination with your other physicians where that is useful
Clinical, and separate.
Peptide therapy does not sit inside a Circuit. It runs alongside your protocol as a clinical service with its own evaluation and its own timeline.
We measure first
Diagnostics and baseline testing come before any clinical conversation. Without findings there is nothing to prescribe against, and prescribing against nothing is how this field gets its reputation.
We look at everything else first
Sleep, training load, nutrition, and the modalities in your protocol are addressed before we reach for a prescription. Frequently that is where the answer already is.
We prescribe only if it is warranted
If evaluation supports it and it is appropriate and available, it is prescribed with monitoring attached. If it is not, we tell you, and that conversation is part of what you are paying for.
A real field with a wide range.
Peptide therapeutics is a serious area of pharmacology. It is also currently one of the least evenly evidenced areas in wellness, and both things are worth understanding.
Peptides are short chains of amino acids, the same building blocks that form proteins. Insulin is one. So are the GLP-1 medications. Approval and evidence vary enormously across the category, and that variation is the single most important thing to understand.
FDA drug approvals from the perspective of molecules
Peptide and oligonucleotide therapeutics
FDA review of peptides for compounding
Compounding and the FDA
We will tell you which side something sits on
This page deliberately does not list specific compounds. That is not evasion. What is appropriate for you is a clinical decision made after evaluation, and what is legally available is currently subject to active FDA review. Publishing a menu would misrepresent both. Come in, be evaluated, and our physician will tell you exactly what is being considered, what the evidence behind it is, and where it sits regulatorily.
Questions answered.
Which peptides do you offer?
We do not publish a list, and we would be wary of anyone who does. What is appropriate depends on your evaluation, and what is legally available is currently under active FDA review. Our physician will tell you exactly what is being considered for you and why, once there is a basis for that conversation.
Are peptides FDA approved?
Some are, some are not, and the distinction matters enormously. Around 130 peptide drugs hold FDA approval, including insulin and the GLP-1 medications. Many compounds marketed as peptide therapy are not approved for human use and some have never been studied in humans for safety or efficacy.
Why will you not just prescribe what I ask for?
Because that is not medicine, it is order taking. Peptides are potent signalling molecules that interact with endocrine, vascular, and neurologic pathways. Prescribing one because a patient named it, without evaluation or indication, is how this field earned its criticism.
What is happening with FDA regulation right now?
The FDA is actively reviewing which peptide substances are appropriate for pharmaceutical compounding, assessing safety evidence, clinical need, and whether approved alternatives exist. The position may change. We will tell you where things stand at the time you ask rather than relying on what was true last year.
Do I need diagnostics first?
In almost all cases yes. Without findings there is nothing to prescribe against. If you have recent labs, bring them and we will use them rather than repeating work you have already paid for.
What if the answer is no?
Then that is your answer, and it is a legitimate one. You will leave with an explanation of why, and usually with an alternative worth pursuing. A consultation that ends in a considered no has still done its job.
Will you coordinate with my own physician?
Yes, on request, and we would encourage it. If you are under the care of another physician we would rather work alongside them than around them, particularly where medications interact.
Is this covered by insurance?
Generally not. Most of this is elective and falls outside standard coverage. Some diagnostics may be eligible for HSA or FSA reimbursement, and we can provide documentation for submission.
Is it included in membership?
No. Peptide therapy is a clinical service with its own evaluation and its own timeline. It sits alongside membership rather than inside a Circuit.
Measurement comes first.
Almost everyone asking about peptides should begin somewhere else. These are the steps that come before this conversation is useful.
Advanced Longevity Testing
Diagnostics that establish what is actually happening, so any clinical decision has something to work from.
The Executive Protocol
A twelve week programme where clinical evaluation and the facility modalities run as a single plan.
The Modalities
Sixteen modalities addressing recovery, capacity, and cellular energy without a prescription.
Reserve Your Consultation.
This begins with an evaluation rather than a prescription. In it we will:
- Review your history, medications, and current supplements
- Understand what you are actually trying to change
- Determine whether diagnostics are needed first
- Tell you plainly whether this is appropriate for you
- Explain the evidence and regulatory position for anything considered